PRESS
RELEASE
BIOLIFE SOLUTIONS INC. COMPLETES RELOCATION TO BOTHELL, WA
Move to Seattle-Area Biotech Hub Improves Customer Service, Access to Researchers
BOTHELL, WA – April 30, 2007 – BioLife Solutions Inc. (OTC BB: BLFS), a leading developer and manufacturer
of proprietary liquid preservation media for cells, tissues, and organs, today announced it completed the
relocation of its corporate office and operations, except production, to a biotech campus in Bothell, WA, a
suburb of Seattle.
Chief Executive Mike Rice remarked: “Our strategic planning process identified areas for optimizing our
infrastructure to best execute our growth strategies. And this move allows us to better serve all of our
customers and enhance collaborations with leading research centers, including the University of
Washington and the Fred Hutchinson Cancer Research Center.”
Production of BioLife’s patented preservation media products will continue in Owego, NY. The Company is
also evaluating several contract manufacturers to augment production capacity to meet future demand for
its products.
As part of its expanded sales and marketing strategy, BioLife will be exhibiting and presenting at the
following events:
• BIO 2007 annual international convention, May 6-9 in Boston
• American Society of Gene Therapy (ASGT) annual meeting, May 30–June 3 in Seattle
• International Society for Stem Cell Research (ISSCR) annual meeting, June 17-21 in Cairns, Australia
• International Society for Cellular Therapy (ISCT) annual meeting, June 24-27 in Sydney, Australia
This news release contains forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. These forward-looking statements include any
statements that relate to the intent, belief, plans or expectations of the Company or its
management, or that are not a statement of historical fact. Any forward-looking statements in
this news release are based on current expectations and beliefs and are subject to numerous
risks and uncertainties that could cause actual results to differ materially. Some of the specific
factors that could cause BioLife Solutions' actual results to differ materially are discussed in the
Company's recent filings with the Securities and Exchange Commission. BioLife Solutions
disclaims any obligation to update any forward-looking statements as a result of developments
occurring after the date of this press release.